In vitro and in vivo gene delivery by recombinant baculoviruses

Journal of Virology

Volumn 77, Issue 18, 2003, Pages 9799-9808

  Tani, Hideki ^a,d   Limn, Chang Kwang ^a   Yap, Chan Choo ^b   Onishi, Masayoshi ^a   Nozaki, Masami ^a   Nishimune, Yoshitake ^a   Okahashi, Nobuo ^c   Kitagawa, Yoshinori ^a   Watanabe, Rie ^a   Mochizuki, Rika ^a   Moriishi, Kohji ^a   Matsuura, Yoshiharu ^a,c  

^a OSAKA UNIVERSITY   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; BACULOVIRUS; COMPLEMENT ACTIVATION; CONTROLLED STUDY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABIES VIRUS; RAT; REPORTER GENE; SPECIES DIFFERENCE; VESICULAR STOMATITIS VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRUS INACTIVATION; VIRUS RECOMBINANT;

ANIMALS; BACULOVIRIDAE; BRAIN; CELL LINE; GENE THERAPY; GENE TRANSFER, HORIZONTAL; GUANIDINES; HUMANS; MICE; RATS; RECOMBINATION, GENETIC; TRANSDUCTION, GENETIC;

EID: 0141459030     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.18.9799-9808.2003     Document Type: Article

References (45)

1. Airenne, K. J., M. O. Hiltunen, M. P. Turunen, A-M. Turunen, O. H. Laitinen, M. S. Kulomaa, and S. Ylä-Herttuala. 2000. Baculovirus-mediated periadventitial gene transfer to rabbit carotid artery. Gene Ther. 7:1499-1504.
2. Baltzer, A. W., J. D. Whalen, M. Stefanovic-Racic, B. Ziran, P. D. Robbins, and C. H. Evans. 1999. Adenoviral transduction of human osteoblastic cell cultures: a new perspective for gene therapy of bone diseases. Acta Orthop. Scand. 70:419-424.
3. Barsoum, J., R. Brown, M. McKee, and F. M. Boyce. 1997. Efficient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein. Hum. Gene Ther. 8:2011-2018.
4. Blanchard, K. T., and K. Boekelheide. 1997. Adenovirus-mediated gene transfer to rat testis in vivo. Biol. Reprod. 56:495-500.
5. Boyce, F. M., and N. L. R. Bucher. 1996. Baculovirus-mediated gene transfer into mammalian cells. Proc. Natl. Acad. Sci. USA 93:2348-2352.
6. Grabherr, R., W. Ernst, C. Oker-Blom, and I. Jones. 2001. Developments in the use of baculoviruses for the surface display of complex eukaryotic proteins. Trends Biotechnol. 19:231-236.
7. Gronowski, A. M., D. M. Hilbert, K. C. F. Sheehan, G. Garotta, and R. D. Schreiber. 1999. Baculovirus stimulates antiviral effects in mammalian cells. J. Virol. 73:9944-9951.
8. Haeseleer, F., Y. Imanishi, D. A. Saperstein, and K. Palczewski. 2001. Gene transfer mediated by recombinant baculovirus into mouse eye. Investig. Ophthalmol. Vis. Sci. 42:3294-3300.
9. Hanham, C. A., F. Zhao, and G. H. Tignor. 1993. Evidence from the antiidiotypic network that the acetylcholine receptor is a rabies virus receptor. J. Virol. 67:530-542.
10. Hofmann, C., V. Sandig, G. Jennings, M. Rudolph, P. Schlag, and M. Strauss. 1995. Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc. Natl. Acad. Sci. USA 92:10099-10103.
11. Hofmann, C., and M. Strauss. 1998. Baculovirus-mediated gene transfer in the presence of human serum or blood facilitated by inhibition of the complement system. Gene Ther. 5:531-536.
12. Hüser, A., M. Rudolph, and C. Hofmann. 2001. Incorporation of decay-accelerating factor into the baculovirus envelope generates complement-resistant gene transfer vectors. Nat. Biotechnol. 19:451-455.
13. Ikari, N., Y. Sakai, Y. Hitomi, S. Fujii. 1983. New synthetic inhibitor to the alternative complement pathway. Immunology 49:685-691.
14. Kalajzic, I., M. L. Stover, P. Liu, Z. Kalajzic, D. W. Rowe, and A. C. Lichtler. 2001. Use of VSV-G pseudotyped retroviral vectors to target murine osteoprogenitor cells. Virology 284:37-45.
15. Karsenty, G. 1999. The genetic transformation of bone biology. Genes Dev. 13:3037-3051.
16. Kim, J. H., H. S. Jung-Ha, H. T. Lee, and K. S. Chung. 1997. Development of a positive method for male stem cell-mediated gene transfer in mouse and pig. Mol. Reprod. Dev. 46:515-526.
17. Koseki, T., Y. Gao, N. Okahashi, Y. Murase, T. Tsujisawa, T. Sato, K. Yamato, and T. Nishihara. 2002. Role of TGF-beta family in osteoclastogenesis induced by RANKL. Cell. Signal. 14:31-36.
18. Kost, T. A., and J. P. Condreay. 2002. Recombinant baculoviruses as mammalian cell gene-delivery vectors. Trends Biotechnol. 20:173173-180.
19. Lehtolainen. P., K. Tyynelä, J. Kannasto, K. J. Airenne, and S. Ylä-Herttuala. 2002. Baculoviruses exhibit restricted cell type specificity in rat brain: a comparison of baculovirus- and adenovirus-mediated intracerebral gene transfer in vivo. Gene Ther. 9:1693-1699.
20. Matsuura, Y., R. D. Possee, H. A. Overton, and D. H. L. Bishop. 1987. Baculovirus expression vector: the requirements for high level expression of proteins, including glycoproteins. J. Gen. Virol. 68:1233-1250.
21. Mehrara, B. J., P. B. Saadeh, D. S. Stelnbrech, M. Dudziak J. A. Spector, J. A. Greenwald, G. K. Gittes, and M. T. Longaker. 1999. Adenovirus-mediated gene therapy of osteoblasts in vitro and in vivo. J. Bone Mineral Res. 14:1290-1301.
22. Miller, L. K., and P. D. Friesen. 2001. Insect viruses, p. 599-628. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott-Raven, Philadelphia, Pa.
23. Miyao, Y., K. Ikenaka, H. Kishima, M. Tamura, K. Nakamura, M. Kurumi, T. Hayakawa, and K. Shimizu. 1997. FUT-175, a synthetic inhibitor of the complement pathway, protects against the inactivation of infectious retroviruses by human serum. Hum. Gene Ther. 8:1575-1583.
24. Mulligan, R. C. 1993. The basic science of gene therapy. Science 260:926-932.
25. Muramatsu, T., O. Shibata, S. Ryoki, Y. Ohmori, and J. Okumura. 1997. Foreign gene expression in the mouse testis by localized in vivo gene transfer. Biochem. Biophys. Res. Commun. 233:45-49.
26. Niinobe, M., Y. Ueno, Y. Hitomi, and S. Fujii. 1984. Detection of intermediary Clr with complete active site, with a synthetic proteinase inhibitor. FEBS Lett. 172:159-162.
27. Niwa, H., K. Yamamura, and J. Miyazaki. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193-200.
28. Ogawa, T., J. M. Arechaga, M. R. Avarbock, R. L. Brinster. 1997. Transplantation of testis germinal cells into mouse seminiferous tubules. Int. J. Dev. Biol. 41:111-122.
29. KIp1. J. Cell. Biochem. 80:339-345.
30. Ory, D. S., B. A. Neugeboren, and R. C. Mulligan. 1996. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. USA 93:11400-11406.
31. Pfeifer, P. H., M. S. Kawahara, and T. E. Hugli. 1999. Possible mechanism for in vitro complement activation in blood and plasma samples: FUT-175/EDTA controls in vitro complement activation. Clin. Chem. 45:1190-1199.
32. Pieroni, L., D. Maione, and N. La Monica. 2001. In vivo gene transfer in mouse skeletal muscle mediated by baculovirus vectors. Hum. Gene Ther. 12:871-881.
33. Pieroni, L., and N. La Monica. 2001. Towards the use of baculovirus as a gene therapy vector. Curr. Opin. Mol. Ther. 3:465-467.
34. Ruggieri, A., T. Harada, Y. Matsuura, and T. Miyamura. 1997. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology 229:68-76.
35. Sandig, V., C. Hofmann, S. Steinert, G. Jennings, P. Schlag, and M. Strauss. 1996. Gene transfer into hepatocytes and human liver tissue by baculovirus vectors. Hum. Gene Ther. 7:1937-1945.
36. Sandig, V., and M. Strauss. 1996. Liver-directed gene transfer and application to therapy. J. Mol. Med. 74:205-212.
37. Sarkis, C., C. Serguera, S. Petres, D. Buchet, J.-L. Ridet, L. Edelman, and J. Mallet. 2000. Efficient transduction of neural cells in vitro and in vivo by a baculovirus-derived vector. Proc. Natl. Acad. Sci. USA 97:14638-14643.
38. Shoji, I., H. Aizaki, H. Tani, K. Ishii, T. Chiba, I. Saito, T. Miyamura, and Y. Matsuura. 1997. Efficient gene transfer into various mammalian cells, including non-hepatic cells, by baculovirus vectors. J. Gen. Virol. 78:2657-2664.
39. Song, S. U., S.-H. Shin, S.-K. Kim, G.-S. Choi, W.-C. Kim, M.-H. Lee, S.-J. Kim, I.-H. Kim, M.-S. Choi, Y.-J. Hong, and K.-H. Lee. 2003. Effective transduction of osteogenic sarcoma cells by a baculovirus vector. J. Gen. Virol. 84:697-703.
40. Tamura, Y., M. Hirado, K. Okamura, Y. Minato, and S. Fujii. 1977. Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, C1r, and C1 esterase. Biochim. Biophys. Acta 484:417-422.
41. Tani, H., M. Nishijima, H. Ushijima, T. Miyamura, and Y. Matsuura. 2001. Characterization of cell-surface determinants important for baculovirus infection. Virology 279:343-353.
42. Tjia, S. T., G. M. zu Altenschildesche, and W. Doerfler. 1983. Autographa californica nuclear polyhedrosis virus (AcNPV) DNA does not persist in mass cultures of mammalian cells. Virology 125:107-117.
43. Tuchiya, K., Y. Matsuura, A. Kawai, A. Ishihama, and S. Ueda. 1992. Characterization of rabies virus glycoprotein expressed by recombinant baculovirus. Virus Res. 25:1-13.
44. Tuffereau, C., J. Bénéjean, D. Blondel, B. Kieffer, and A. Flamand. 1998. Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus. EMBO J. 17:7250-7259.
45. Yap, C. C., K. Ishii, Y. Aoki, H. Aizaki, H. Tani, H. Shimizu, Y. Ueno, T. Miyamura, and Y. Matsuura. 1997. A hybrid baculovirus-T7 RNA polymerase system for recovery of an infectious virus from cDNA. Virology 231:192-200.